Patricia Zilliox is the founder of Eyevensys. Eyevensys has raised $33M in total funding. Latest round: Series B. Backed by Korea Investment Partners.
Patricia Zilliox is the founder and CEO of Eyevensys, a French clinical-stage biotechnology company focused on ophthalmic diseases. She successfully raised approximately €27 million in a Series B round and is now seeking to raise between €50–€70 million in a Series C fundraise. Zilliox also established a U.S. presence for the startup to help European biotechs advance globally.
Full founder directory · Investor directory · Company funding database · Fundraising library